Showing results (1981-1990 of 2,694) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|March 7, 2024
Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational studyMarcelo Brito, Rosilene Rufatto, José Diego Brito-Sousa, et al.
The Lancet. Infectious Diseases|July 4, 2024
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trialHeather L Platt, Christopher Bruno, Erik Buntinx, et al.
The Lancet. Infectious Diseases|July 18, 2024
Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir-ritonavir in patients hospitalised with COVID-19: a target trial emulation studyMing Hong Choi, Eric Yuk Fai Wan, Ian Chi Kei Wong, et al.
The Lancet. Infectious Diseases|February 8, 2024
Safety and efficacy of onradivir in adults with acute uncomplicated influenza A infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trialZifeng Yang, Zhengtu Li, Yangqing Zhan, et al.
The Lancet. Infectious Diseases|January 21, 2024
Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control studyEspoir Bwenge Malembaka, Patrick Musole Bugeme, Chloe Hutchins, et al.
The Lancet. Infectious Diseases|September 7, 2024
Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescentsVera Buerger, Sandra Hadl, Martina Schneider, et al.
The Lancet. Infectious Diseases|September 26, 2024
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global accessJonne Terstappen, Sarah F Hak, Anant Bhan, et al.
The Lancet. Infectious Diseases|September 27, 2024
Safety and immunogenicity of a single-dose omicron-containing COVID-19 vaccination in adolescents: an open-label, single-arm, phase 2/3 trialAmparo L Figueroa, Dania Torres, Celia Reyes-Acuna, et al.
The Lancet. Infectious Diseases|September 22, 2024
Mosquito-disseminated pyriproxyfen for mosquito-borne disease control in Belo Horizonte, Brazil: a pragmatic, before-after control-intervention paired-series trialFernando Abad-Franch, José Joaquín Carvajal-Cortés, Ana Carolina Lemos Rabelo, et al.
The Lancet. Infectious Diseases|September 21, 2024
Antifungal susceptibility testing: applicability of methods and strategies for improving access in resource-constrained settingsRichard Kwizera, Alireza Abdolrasouli, Guillermo Garcia-Effron, et al.
Pageof 270